Hongmei Dong, Liang Du, Liang Du, Liang Du, Songwang Cai, Wan Lin, . . . Hao Zhang. (2022). Tyrosine Phosphatase PTPRO Deficiency in ERBB2-Positive Breast Cancer Contributes to Poor Prognosis and Lapatinib Resistance. Frontiers Media S.A..
Chicago Style (17th ed.) CitationHongmei Dong, et al. Tyrosine Phosphatase PTPRO Deficiency in ERBB2-Positive Breast Cancer Contributes to Poor Prognosis and Lapatinib Resistance. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationHongmei Dong, et al. Tyrosine Phosphatase PTPRO Deficiency in ERBB2-Positive Breast Cancer Contributes to Poor Prognosis and Lapatinib Resistance. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.